Skip to main content
IDXX
NASDAQ Life Sciences

IDEXX Lifts Full-Year Outlook as Diagnostics Demand Offsets 1.8% Drop in Vet Visits; Shares Jump 19%

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$659.195
Mkt Cap
$51.932B
52W Low
$500.61
52W High
$769.98
52W Position info
32% above low
Off High info
14% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

IDXX sits 32% above its 52-week low of $500.61.

Summary

IDEXX beat on Q3 and raised full-year profit and revenue guidance, and the stock is up more than 19% in morning trading. Revenue rose 10% to $1.21 billion against a $1.19 billion consensus, with EPS up 18% to $4.01. The pitch is that diagnostics intensity, not clinic traffic, carries growth: US same-store clinical visits fell an estimated 1.8% in the quarter, yet recurring diagnostics revenue in companion animal grew 9.6% in the US on higher testing frequency and uptake of the InVue Dx analyzer and CancerDx dog cancer screen. Management was explicit that innovation and commercial execution are doing the work, not a visit rebound. This follows the Q3 release furnished in today's 8-K and the earlier wire report on the beat; the guidance raise and the size of the share move are the new information. Watch whether the raised bar holds if vet visit declines persist into Q4.

At the time of this announcement, IDXX was trading at $659.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $51.9B. The 52-week trading range was $500.61 to $769.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IDXX - Latest Insights

IDXX
Nov 02, 2026, 4:29 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $670.00
Real-time Price: $698.47 info
Change: +$28.47 (+4%) info
Market Cap: $55.03B info
IDXX
Nov 02, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $555.00
Real-time Price: $698.47 info
Change: +$143.47 (+26%) info
Market Cap: $55.03B info
IDXX
Nov 02, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $544.00
Real-time Price: $698.47 info
Change: +$154.47 (+28%) info
Market Cap: $55.03B info
IDXX
Sep 16, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $505.26
Real-time Price: $698.47 info
Change: +$193.21 (+38%) info
Market Cap: $55.03B info
IDXX
Aug 04, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $588.09
Real-time Price: $698.47 info
Change: +$110.38 (+19%) info
Market Cap: $55.03B info